Parabase Genomics’ is committed to improving neonatal care through the development of early diagnostics for actionable inherited disorders. The company’s NewbornDx Test™ is designed to be rapid and less invasive, using dried blood spots, and incorporate the most damaging disorders. Physicians can now make precise treatment decisions based on an individual’s molecular profile rather than severe symptomology. The test can assist physicians to make prompt and informed decisions while the patient is still in the hospital by matching them to the best treatment options.
Parabase Genomics has not received any reviews.
Parabase Genomics has not received any endorsements.